Total Payments
$1,062
2024 Payments
$160.68
Companies
20
Transactions
50
Medicare Patients
6,466
Medicare Billing
$268,973
Payment Breakdown by Category
Food & Beverage$1,062 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,062 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $214.91 | 9 | $0 (2022) |
| Medtronic, Inc. | $99.10 | 2 | $0 (2022) |
| Abbott Laboratories | $92.98 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $87.37 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $87.28 | 6 | $0 (2020) |
| ABIOMED | $79.48 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $59.52 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $45.36 | 2 | $0 (2017) |
| Amgen Inc. | $43.14 | 3 | $0 (2019) |
| PFIZER INC. | $39.69 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160.68 | 5 | ABIOMED ($79.48) |
| 2023 | $51.17 | 2 | PFIZER INC. ($28.04) |
| 2022 | $141.66 | 4 | Medtronic, Inc. ($99.10) |
| 2021 | $11.77 | 1 | Bard Peripheral Vascular, Inc. ($11.77) |
| 2020 | $26.04 | 2 | E.R. Squibb & Sons, L.L.C. ($26.04) |
| 2019 | $166.26 | 10 | Boston Scientific Corporation ($38.39) |
| 2018 | $243.66 | 13 | Boston Scientific Corporation ($89.53) |
| 2017 | $260.69 | 13 | BOSTON SCIENTIFIC CORPORATION ($72.67) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $79.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Philips North America LLC | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $24.21 | General |
| Category: Medical Device | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $23.13 | General |
| Category: Medical Device | ||||||
| 03/08/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2022 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $78.44 | General |
| Category: Aortic Stent Grafts | ||||||
| 06/14/2022 | Boston Scientific Corporation | General - Brady (Device) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: General - Brady_CRM | ||||||
| 05/11/2022 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Pacemakers | ||||||
| 03/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2021 | Bard Peripheral Vascular, Inc. | VENOVO (Device) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 02/10/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: Cardiovascular | ||||||
| 01/31/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: Cardiovascular | ||||||
| 12/14/2019 | Boston Scientific Corporation | GENERAL TACHY (Device) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: TACHY | ||||||
| 12/12/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: THERAPIES | ||||||
| 11/18/2019 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/01/2019 | CardioFocus, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: ATRIAL FIBRILLATION | ||||||
| 05/31/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.51 | General |
| Category: Cardiovascular | ||||||
| 04/17/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardiology | ||||||
| 02/13/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.33 | General |
| 01/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/02/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Cardiovascular | ||||||
| 12/17/2018 | Boston Scientific Corporation | GENERAL TACHY (Device) | Food and Beverage | In-kind items and services | $35.54 | General |
| Category: TACHY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,339 | 1,527 | $266,213 | $63,918 |
| 2022 | 19 | 1,416 | 1,616 | $255,226 | $70,490 |
| 2021 | 17 | 1,742 | 2,065 | $258,645 | $77,926 |
| 2020 | 13 | 1,969 | 2,822 | $137,895 | $56,639 |
Total Patients
6,466
Total Services
8,030
Medicare Billing
$268,973
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 446 | 461 | $118,837 | $21,937 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 177 | $41,897 | $14,187 | 33.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 74 | $23,976 | $7,349 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 70 | $11,038 | $4,266 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $15,260 | $3,755 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 49 | $8,624 | $2,968 | 34.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 270 | 323 | $8,994 | $1,946 | 21.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 30 | 36 | $6,516 | $1,521 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,557 | $1,171 | 25.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 18 | 40 | $4,077 | $789.48 | 19.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 15 | 15 | $3,593 | $740.74 | 20.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 23 | 49 | $4,345 | $669.94 | 15.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 17 | $1,768 | $624.32 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,179 | $379.98 | 32.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $1,478 | $309.40 | 20.9% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 15 | 15 | $1,335 | $262.50 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 33 | $1,955 | $251.44 | 12.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 13 | $1,177 | $238.00 | 20.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 21 | 22 | $3,234 | $212.12 | 6.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 16 | 16 | $1,248 | $205.35 | 16.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 11 | 11 | $649.00 | $97.38 | 15.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 17 | 17 | $476.00 | $37.76 | 7.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 369 | 378 | $86,658 | $18,368 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 184 | $42,931 | $15,774 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $34,060 | $10,700 | 31.4% |
About Dr. Stephen Mackerrow, M.D
Dr. Stephen Mackerrow, M.D is a Interventional Cardiology healthcare provider based in Farmington, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225075526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Mackerrow, M.D has received a total of $1,062 in payments from pharmaceutical and medical device companies, with $160.68 received in 2024. These payments were reported across 50 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,062).
As a Medicare-enrolled provider, Mackerrow has provided services to 6,466 Medicare beneficiaries, totaling 8,030 services with total Medicare billing of $268,973. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Interventional Cardiology
- Location Farmington, NM
- Active Since 06/02/2006
- Last Updated 11/08/2024
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1225075526
Products in Payments
- ENTRESTO (Drug) $87.37
- ELIQUIS (Drug) $87.28
- Impella (Device) $79.48
- ENDURANT IIS (Device) $78.44
- XARELTO (Drug) $59.52
- Circulatory Support (Device) $54.71
- GENERAL TACHY (Device) $49.40
- (5091) Amb Mon & Diag Und (Device) $47.34
- Lexiscan (Drug) $45.36
- GENERAL - TACHY SYSTEMS (Device) $44.16
- HeartMate 3 Left Ventricular Dev (Device) $38.27
- Corlanor (Drug) $30.77
- GENERAL - TACHY (Device) $28.51
- VYNDAQEL (Drug) $28.04
- GENERAL THERAPIES (Device) $27.52
- RESONATE (Device) $25.00
- Reveal LINQ (Device) $23.08
- Veltassa (Drug) $22.51
- NORTHERA (Drug) $20.81
- MICRA (Device) $20.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Farmington
Andre Bouhasin, Md, MD
Interventional Cardiology — Payments: $68,500
Interventional Cardiology $68,500
Christopher Kim, Md, MD
Interventional Cardiology — Payments: $43,867
Interventional Cardiology $43,867
Dr. Stephen Bernard, M.d, M.D
Interventional Cardiology — Payments: $36,402
Interventional Cardiology $36,402
Dr. Sudhakar Girotra
Interventional Cardiology — Payments: $4,417
Interventional Cardiology $4,417